Clinical Trials Browser

Phase 2 × Completed × Solid Tumor × Clear all

NCT03861156 2024-04-09

D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer

Phase 2 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT04346381 2023-09-18

Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT05898451 2023-06-12

R-2

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT02447419 2022-06-15

Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT03220854 2022-01-10

SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx

Phase 2 Completed

5 enrolled 12 charts

Other solid neoplasm

Solid Tumor

NCT04180384 2021-07-29

A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT02449538 2017-02-17

Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumor